MetaADEDB 2.0 @ LMMD
Acyclovir
(MKUXAQIIEYXACX-UHFFFAOYSA-N)
Structure
SMILES
OCCOCn1cnc2c1nc(N)[nH]c2=O
Type(s)
Approved
ATC code(s)
D06BB03; D06BB53; J05AB01; S01AD03
Molecular Formula:
C8H11N5O3
Molecular Weight:
225.205
Log P:
-0.7506
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
3
TPSA:
119.05
CAS Number(s):
59277-89-3; 141294-79-3
Synonym(s)
1.
Acyclovir
2.
Acycloguanosine
3.
9-((2-Hydroxyethoxy)methyl)guanine
4.
Aci-Sanorania
5.
Acic
6.
Aciclobeta
7.
Aciclostad
8.
Aciclovir
9.
Aciclovir Alonga
10.
Aciclovir-Sanorania
11.
Acifur
12.
Acipen Solutab
13.
Acivir
14.
Activir
15.
Acyclo-V
16.
Acyclovir Sodium
17.
Antiherpes Creme
18.
Avirax
19.
Cicloferon
20.
Clonorax
21.
Cusiviral
22.
Genvir
23.
Herpetad
24.
Herpofug
25.
Herpotern
26.
Herpoviric
27.
Isavir
28.
Laciken
29.
Mapox
30.
Maynar
31.
Milavir
32.
Opthavir
33.
Supraviran
34.
Viclovir
35.
Vipral
36.
Virax-Puren
37.
Virherpes
38.
Virmen
39.
Virolex
40.
Virupos
41.
Virzin
42.
Wellcome-248U
43.
Zoliparin
44.
Zovirax
45.
Zyclir
46.
aciclovir von ct
47.
Aci Sanorania
48.
Aciclovir Sanorania
49.
Acyclo V
50.
Alonga, Aciclovir
51.
Sodium, Acyclovir
52.
Solutab, Acipen
53.
Virax Puren
54.
ViraxPuren
55.
Wellcome 248U
56.
Wellcome248U
External Link(s)
MeSHD000212
PubChem Compound135398513
2022
BindingDB50021776
50103518
ChEBI2453
CHEMBLCHEMBL184
DrugBankDB00787
DrugCentral85
IUPHAR/BPS Guide to PHARMACOLOGY4829
KEGGcpd:C06810
dr:D00222
Therapeutic Target DatabaseD0B5MP
D0Y9QQ
ZINC1530555
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 315
Canada Vigilance: 31
Canada Vigilance
US FAERS
2Acute kidney injuryFAERS: 126
Canada Vigilance: 62

View details

CTD
Canada Vigilance
US FAERS
3NauseaFAERS: 777571352CTD
OFFSIDES
SIDER
US FAERS
4HeadacheFAERS: 63
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
5VomitingFAERS: 60
Canada Vigilance: 1
7571352
8322628
CTD
SIDER
Canada Vigilance
US FAERS
6Pharmaceutical product complaintFAERS: 57US FAERS
7Product quality issueFAERS: 56
Canada Vigilance: 3
Canada Vigilance
US FAERS
8PruritusFAERS: 55SIDER
US FAERS
9Altered state of consciousnessFAERS: 48OFFSIDES
SIDER
US FAERS
10DizzinessFAERS: 48
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
11FatigueFAERS: 44
Canada Vigilance: 2
3711686CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
12ErythemaFAERS: 41
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
13SomnolenceFAERS: 41SIDER
US FAERS
14MalaiseFAERS: 39
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
15AgitationFAERS: 38SIDER
US FAERS
16Blood creatinine increasedFAERS: 38
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
SIDER
US FAERS
17DeliriumFAERS: 37

View details

CTD
SIDER
US FAERS
18Depressed Level of ConsciousnessFAERS: 37
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
19DisorientationFAERS: 36
Canada Vigilance: 1
Canada Vigilance
US FAERS
20Medication ErrorFAERS: 36US FAERS
21UrticariaFAERS: 34SIDER
US FAERS
22AstheniaFAERS: 33SIDER
US FAERS
23HypersensitivityFAERS: 32SIDER
US FAERS
24OverdoseFAERS: 32OFFSIDES
US FAERS
25RestlessnessFAERS: 32US FAERS
26Pathogen resistanceFAERS: 31US FAERS
27DysarthriaFAERS: 304062110
9496746
14658398
CTD
SIDER
US FAERS
28Mental status changesFAERS: 30OFFSIDES
US FAERS
29PainFAERS: 30
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
30Abdominal PainFAERS: 29SIDER
US FAERS
31nervous system disorderFAERS: 29SIDER
US FAERS
32Product substitution issueFAERS: 27US FAERS
33TremorFAERS: 278671884CTD
SIDER
US FAERS
34AphasiaFAERS: 26US FAERS
35Burning sensationFAERS: 26US FAERS
36Drug resistanceFAERS: 24US FAERS
37treatment failureFAERS: 24US FAERS
38Drug exposure during pregnancyFAERS: 21US FAERS
39ExtravasationFAERS: 21US FAERS
40Toxicity to various agentsFAERS: 21US FAERS
41AlopeciaFAERS: 20
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
42EncephalitisFAERS: 191476483CTD
US FAERS
43EpilepsyFAERS: 19US FAERS
44MyoclonusFAERS: 19
Canada Vigilance: 2
4062110
7571352
7973922
CTD
Canada Vigilance
US FAERS
45Eye painFAERS: 17OFFSIDES
US FAERS
46Skin lesionFAERS: 16
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
47ThrombocytopeniaFAERS: 16
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
48Accidental overdoseFAERS: 15US FAERS
49Application site irritationFAERS: 15SIDER
US FAERS
50AtaxiaFAERS: 15
Canada Vigilance: 2
7571352CTD
SIDER
Canada Vigilance
US FAERS
51ArthralgiaFAERS: 14
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
52DehydrationFAERS: 14SIDER
US FAERS
53Product solubility abnormalFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
54Respiratory FailureFAERS: 14OFFSIDES
US FAERS
55Abdominal discomfortFAERS: 13SIDER
US FAERS
56Application site painFAERS: 13
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
57LethargyFAERS: 13

View details

CTD
SIDER
US FAERS
58Maternal exposure during pregnancyFAERS: 13US FAERS
59Memory impairmentFAERS: 13US FAERS
60No adverse eventFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
61OliguriaFAERS: 13US FAERS
62Product use issueFAERS: 13US FAERS
63Renal tubular necrosisFAERS: 13OFFSIDES
US FAERS
64AnxietyFAERS: 12
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
65Disseminated Intravascular CoagulationFAERS: 12OFFSIDES
SIDER
US FAERS
66Drug level increasedFAERS: 12US FAERS
67DyslaliaFAERS: 12OFFSIDES
US FAERS
68DysphoniaFAERS: 12
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
69Incorrect dose administeredFAERS: 12US FAERS
70ScabFAERS: 12OFFSIDES
US FAERS
71Visual ImpairmentFAERS: 12US FAERS
72Back PainFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
73Crystal nephropathyFAERS: 11US FAERS
74Disease recurrenceFAERS: 11OFFSIDES
US FAERS
75Drug administration errorFAERS: 11US FAERS
76Drug toxicityFAERS: 11OFFSIDES
US FAERS
77HypotensionFAERS: 119865134CTD
SIDER
US FAERS
78IncoherentFAERS: 11US FAERS
79Incorrect route of drug administrationFAERS: 11US FAERS
80Lip swellingFAERS: 11US FAERS
81Viral mutation identifiedFAERS: 11US FAERS
82Alanine Aminotransferase IncreasedFAERS: 10OFFSIDES
SIDER
US FAERS
83AmnesiaFAERS: 10US FAERS
84Aspartate Aminotransferase IncreasedFAERS: 10SIDER
US FAERS
85Blood urea increasedFAERS: 10OFFSIDES
SIDER
US FAERS
86DiscomfortFAERS: 10SIDER
US FAERS
87Drug dispensing errorFAERS: 10US FAERS
88InfectionFAERS: 10OFFSIDES
US FAERS
89Electroencephalogram abnormalFAERS: 9US FAERS
90Feeling abnormalFAERS: 9SIDER
US FAERS
91PalpitationsFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
92PancreatitisFAERS: 9US FAERS
93Psychiatric symptomFAERS: 9US FAERS
94VIIth nerve paralysisFAERS: 9US FAERS
95AnorexiaFAERS: 8OFFSIDES
SIDER
US FAERS
96Blood sodium decreasedFAERS: 8US FAERS
97BronchospasmFAERS: 8US FAERS
98Chest PainFAERS: 8SIDER
US FAERS
99DiplopiaFAERS: 8US FAERS
100Expired drug administeredFAERS: 8US FAERS
101Injection site necrosisFAERS: 8US FAERS
102MyalgiaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
103Product use in unapproved indicationFAERS: 8US FAERS
104RhabdomyolysisFAERS: 8US FAERS
105SwellingFAERS: 8US FAERS
106Therapeutic response unexpectedFAERS: 8US FAERS
107VertigoFAERS: 8SIDER
US FAERS
108AngioedemaFAERS: 7SIDER
US FAERS
109AnuriaFAERS: 7OFFSIDES
SIDER
US FAERS
110Application site erythemaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
111BlindnessFAERS: 7
Canada Vigilance: 4
Canada Vigilance
US FAERS
112Cardiac ArrestFAERS: 7US FAERS
113ChromaturiaFAERS: 7US FAERS
114DeafnessFAERS: 7US FAERS
115Drug effect incompleteFAERS: 7US FAERS
116Genital HerpesFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
117Infusion Site ExtravasationFAERS: 7OFFSIDES
US FAERS
118Metabolic acidosisFAERS: 7OFFSIDES
US FAERS
119Musculoskeletal stiffnessFAERS: 7OFFSIDES
US FAERS
120Oropharyngeal painFAERS: 7OFFSIDES
SIDER
US FAERS
121PancytopeniaFAERS: 7US FAERS
122Rash erythematousFAERS: 7US FAERS
123Respiratory distressFAERS: 7US FAERS
124Spina BifidaFAERS: 7US FAERS
125Stevens-Johnson SyndromeFAERS: 725811541CTD
OFFSIDES
SIDER
US FAERS
126Urinary RetentionFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
127Wrong technique in product usage processFAERS: 7US FAERS
128Blood creatine phosphokinase increasedFAERS: 6US FAERS
129BradycardiaFAERS: 69865134CTD
US FAERS
130BronchopneumoniaFAERS: 6US FAERS
131Cerebral atrophyFAERS: 6US FAERS
132Chest discomfortFAERS: 6US FAERS
133Diet refusalFAERS: 6US FAERS
134Dry skinFAERS: 6OFFSIDES
US FAERS
135DysgeusiaFAERS: 6SIDER
US FAERS
136Expired product administeredFAERS: 6US FAERS
137Eye irritationFAERS: 6US FAERS
138General physical health deteriorationFAERS: 6OFFSIDES
US FAERS
139Graft dysfunctionFAERS: 6OFFSIDES
US FAERS
140Injection site extravasationFAERS: 6US FAERS
141NervousnessFAERS: 6US FAERS
142PhlebitisFAERS: 6SIDER
US FAERS
143ProteinuriaFAERS: 6
Canada Vigilance: 1
8442906CTD
Canada Vigilance
US FAERS
144SepsisFAERS: 6US FAERS
145Skin necrosisFAERS: 6US FAERS
146ThirstFAERS: 6
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
147Throat irritationFAERS: 6US FAERS
148Transaminases increasedFAERS: 6US FAERS
149Unresponsive to stimuliFAERS: 6OFFSIDES
US FAERS
150Visual disturbanceFAERS: 6US FAERS
151AbasiaFAERS: 5US FAERS
152Accidental exposureFAERS: 5US FAERS
153AscitesFAERS: 5OFFSIDES
US FAERS
154AsterixisFAERS: 5US FAERS
155BradykinesiaFAERS: 5US FAERS
156BradyphreniaFAERS: 5US FAERS
157Corneal lesionFAERS: 5US FAERS
158DermatitisFAERS: 5SIDER
US FAERS
159Drug prescribing errorFAERS: 5US FAERS
160EpistaxisFAERS: 5OFFSIDES
US FAERS
161Erythema MultiformeFAERS: 5SIDER
US FAERS
162GlaucomaFAERS: 5US FAERS
163HepatotoxicityFAERS: 5OFFSIDES
US FAERS
164Mouth swellingFAERS: 5US FAERS
165NeuralgiaFAERS: 5
Canada Vigilance: 1
16682531CTD
OFFSIDES
Canada Vigilance
US FAERS
166NeutropeniaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
167NystagmusFAERS: 5US FAERS
168ParesisFAERS: 5US FAERS
169Peripheral swellingFAERS: 5US FAERS
170PhotophobiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
171SyncopeFAERS: 5US FAERS
172VasculitisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
173WheezingFAERS: 5US FAERS
174White blood cell count decreasedFAERS: 5US FAERS
175jaundiceFAERS: 5SIDER
US FAERS
176Accidental exposure to productFAERS: 4US FAERS
177Antiviral drug level above therapeuticFAERS: 4US FAERS
178Application site reactionFAERS: 4SIDER
US FAERS
179Cerebral InfarctionFAERS: 4US FAERS
180CheilitisFAERS: 4US FAERS
181ChokingFAERS: 4US FAERS
182Corneal OpacityFAERS: 4US FAERS
183Cytomegalovirus syndromeFAERS: 4US FAERS
184Disease ProgressionFAERS: 4OFFSIDES
US FAERS
185Drug ineffective for unapproved indicationFAERS: 4US FAERS
186Emotional disorderFAERS: 4US FAERS
187Emotional distressFAERS: 4OFFSIDES
US FAERS
188Flank PainFAERS: 4US FAERS
189GoutFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
190Hallucinations, mixedFAERS: 4SIDER
US FAERS
191HepatitisFAERS: 4OFFSIDES
SIDER
US FAERS
192Immune thrombocytopenic purpuraFAERS: 4US FAERS
193Incorrect drug administration durationFAERS: 4US FAERS
194Incorrect drug dosage form administeredFAERS: 4US FAERS
195Injection site vesiclesFAERS: 4US FAERS
196KeratitisFAERS: 4US FAERS
197LeukopeniaFAERS: 42741918CTD
SIDER
US FAERS
198MacrocytosisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
199MonoplegiaFAERS: 4US FAERS
200Nuchal RigidityFAERS: 4US FAERS
201ParanoiaFAERS: 4OFFSIDES
US FAERS
202PneumoniaFAERS: 4US FAERS
203Posterior reversible encephalopathy syndromeFAERS: 4US FAERS
204Prescribed underdoseFAERS: 4US FAERS
205Product coating issueFAERS: 4US FAERS
206RetinitisFAERS: 4US FAERS
207RhinitisFAERS: 4US FAERS
208Sinus bradycardiaFAERS: 4US FAERS
209Skin irritationFAERS: 4US FAERS
210SoliloquyFAERS: 4US FAERS
211Status EpilepticusFAERS: 4US FAERS
212StomatitisFAERS: 4US FAERS
213TachycardiaFAERS: 4SIDER
US FAERS
214Therapy cessationFAERS: 4US FAERS
215Unevaluable eventFAERS: 4OFFSIDES
US FAERS
216Urinary tract infectionFAERS: 4US FAERS
217Viral vasculitisFAERS: 4US FAERS
218Weight decreasedFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
219Wrong technique in drug usage processFAERS: 4US FAERS
220AgranulocytosisFAERS: 3US FAERS
221Anaphylactic shockFAERS: 3SIDER
US FAERS
222Anaphylactoid ReactionFAERS: 3US FAERS
223Blister ruptureFAERS: 3US FAERS
224Blood creatine increasedFAERS: 3US FAERS
225Blood urine presentFAERS: 3US FAERS
226Cerebral ventricle dilatationFAERS: 3US FAERS
227ConstipationFAERS: 3SIDER
US FAERS
228Corneal epithelium disorderFAERS: 3US FAERS
229CryingFAERS: 3US FAERS
230Delusional disorder, persecutory typeFAERS: 3US FAERS
231DementiaFAERS: 3US FAERS
232Depressed moodFAERS: 3US FAERS
233DisabilityFAERS: 3US FAERS
234Drug administered to patient of inappropriate ageFAERS: 3US FAERS
235DysuriaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
236Elevated moodFAERS: 3US FAERS
237ErysipelasFAERS: 3US FAERS
238Exposure during breast feedingFAERS: 3US FAERS
239Eye InfectionFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
240Gait inabilityFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
241Gastrointestinal perforationFAERS: 3US FAERS
242Genital burning sensationFAERS: 3US FAERS
243Glasgow coma scale abnormalFAERS: 3US FAERS
244HemiparesisFAERS: 3US FAERS
245Hepatitis BFAERS: 36841304CTD
OFFSIDES
US FAERS
246HypersomniaFAERS: 3US FAERS
247HypophagiaFAERS: 3OFFSIDES
US FAERS
248IncontinenceFAERS: 3US FAERS
249Intestinal PerforationFAERS: 3US FAERS
250LeukocytosisFAERS: 3SIDER
US FAERS
251Lip erosionFAERS: 3OFFSIDES
US FAERS
252Live BirthFAERS: 3US FAERS
253Meningitis herpesFAERS: 3US FAERS
254MydriasisFAERS: 3US FAERS
255Nasal discomfortFAERS: 3US FAERS
256NasopharyngitisFAERS: 3SIDER
US FAERS
257NecrosisFAERS: 315969948
21319040
CTD
SIDER
US FAERS
258Nerve injuryFAERS: 3US FAERS
259Obstructive nephropathyFAERS: 3US FAERS
260Oral painFAERS: 3US FAERS
261PoisoningFAERS: 3US FAERS
262PregnancyFAERS: 3US FAERS
263Product container issueFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
264Product physical issueFAERS: 3US FAERS
265Product taste abnormalFAERS: 3US FAERS
266Product use complaintFAERS: 3US FAERS
267Prothrombin time abnormalFAERS: 3US FAERS
268Purulent dischargeFAERS: 3US FAERS
269Renal painFAERS: 3SIDER
US FAERS
270Respiratory arrestFAERS: 3US FAERS
271Skin ErosionFAERS: 3OFFSIDES
US FAERS
272Therapeutic product cross-reactivityFAERS: 3US FAERS
273ThrombophlebitisFAERS: 33598154CTD
US FAERS
274Virus culture positiveFAERS: 3US FAERS
275Accidental exposure to product by childFAERS: 2US FAERS
276Adverse eventFAERS: 2US FAERS
277Alanine aminotransferase abnormalFAERS: 2US FAERS
278Application site pruritusFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
279ArthritisFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
280Aspartate aminotransferase abnormalFAERS: 2US FAERS
281AthetosisFAERS: 2US FAERS
282Beta 2 microglobulin urine increasedFAERS: 2US FAERS
283Blood glucose increasedFAERS: 2US FAERS
284Blood lactate dehydrogenase increasedFAERS: 2OFFSIDES
US FAERS
285Blood potassium decreasedFAERS: 2OFFSIDES
US FAERS
286Bone marrow toxicityFAERS: 2OFFSIDES
US FAERS
287Bowel movement irregularityFAERS: 2US FAERS
288CellulitisFAERS: 2US FAERS
289Cerebral disorderFAERS: 2US FAERS
290Cerebrovascular accidentFAERS: 2US FAERS
291CholestasisFAERS: 2US FAERS
292ChoreoathetosisFAERS: 2US FAERS
293Cold sweatFAERS: 2US FAERS
294Complications of transplant surgeryFAERS: 2US FAERS
295Corneal ScarFAERS: 2US FAERS
296Corneal dystrophyFAERS: 2US FAERS
297CrystalluriaFAERS: 2US FAERS
298CystitisFAERS: 22837588CTD
US FAERS
299Drug abuseFAERS: 2US FAERS
300Drug dose omissionFAERS: 2US FAERS
301Drug level decreasedFAERS: 2US FAERS
302DysphasiaFAERS: 2US FAERS
303Ear discomfortFAERS: 2US FAERS
304EczemaFAERS: 2SIDER
US FAERS
305Electrocardiogram abnormalFAERS: 2US FAERS
306EncephalomalaciaFAERS: 2US FAERS
307Extra dose administeredFAERS: 2US FAERS
308Facial paralysisFAERS: 2US FAERS
309Failure to ThriveFAERS: 2OFFSIDES
US FAERS
310FlatulenceFAERS: 2SIDER
US FAERS
311FlushingFAERS: 2US FAERS
312Gamma-Glutamyltransferase IncreasedFAERS: 2US FAERS
313Gastric ulcerFAERS: 2US FAERS
314General physical condition abnormalFAERS: 2US FAERS
315Guillain-Barre SyndromeFAERS: 2US FAERS
316Hepatic necrosisFAERS: 2OFFSIDES
US FAERS
317Hepatitis B surface antibody positiveFAERS: 2US FAERS
318Hepatitis B surface antigen positiveFAERS: 2US FAERS
319Herpes pharyngitisFAERS: 2US FAERS
320Herpes simplex pneumoniaFAERS: 2US FAERS
321HyperkinesiaFAERS: 2US FAERS
322HypospadiasFAERS: 2US FAERS
323Impaired work abilityFAERS: 2US FAERS
324ImpetigoFAERS: 2US FAERS
325Inappropriate schedule of drug administrationFAERS: 2US FAERS
326Infusion site necrosisFAERS: 2US FAERS
327Injection site thrombosisFAERS: 2US FAERS
328IridocyclitisFAERS: 2US FAERS
329Malignant HypertensionFAERS: 2US FAERS
330Mechanical ventilationFAERS: 2US FAERS
331MonoparesisFAERS: 2US FAERS
332Multiple SclerosisFAERS: 2US FAERS
333Muscle RigidityFAERS: 2US FAERS
334Neonatal disorderFAERS: 2US FAERS
335Neonatal pneumoniaFAERS: 2US FAERS
336Neonatal respiratory failureFAERS: 2US FAERS
337Neurological decompensationFAERS: 2OFFSIDES
US FAERS
338NeurosyphilisFAERS: 2US FAERS
339Neutropenic sepsisFAERS: 2OFFSIDES
US FAERS
340Neutrophil count decreasedFAERS: 2US FAERS
341Nonspecific reactionFAERS: 2US FAERS
342OphthalmoplegiaFAERS: 2US FAERS
343Optic NeuritisFAERS: 2US FAERS
344Personality ChangeFAERS: 2US FAERS
345Pharyngolaryngeal PainFAERS: 2US FAERS
346Pneumatosis intestinalisFAERS: 2US FAERS
347PneumothoraxFAERS: 2OFFSIDES
US FAERS
348PresyncopeFAERS: 2US FAERS
349Product label issueFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
350Product physical consistency issueFAERS: 2US FAERS
351Product preparation errorFAERS: 2US FAERS
352Prothrombin level decreasedFAERS: 2US FAERS
353Punctate keratitisFAERS: 2SIDER
US FAERS
354PyelonephritisFAERS: 2US FAERS
355QuadriplegiaFAERS: 2US FAERS
356Refusal of treatment by relativeFAERS: 2US FAERS
357Renal failure neonatalFAERS: 2US FAERS
358Renal tubular disorderFAERS: 2US FAERS
359Retinal DetachmentFAERS: 2US FAERS
360Septic ShockFAERS: 2OFFSIDES
US FAERS
361Serum SicknessFAERS: 2US FAERS
362ShockFAERS: 2US FAERS
363Sinus TachycardiaFAERS: 2US FAERS
364SinusitisFAERS: 2OFFSIDES
US FAERS
365Skin reactionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
366SneezingFAERS: 2US FAERS
367Soft tissue necrosisFAERS: 2US FAERS
368StaringFAERS: 2US FAERS
369Therapeutic response unexpected with drug substitutionFAERS: 2US FAERS
370ThrombosisFAERS: 2US FAERS
371TinnitusFAERS: 2OFFSIDES
US FAERS
372Toxic Epidermal NecrolysisFAERS: 2SIDER
US FAERS
373Venous ThrombosisFAERS: 2US FAERS
3742',5'-oligoadenylate synthetase test decreasedFAERS: 1US FAERS
375Abdominal rigidityFAERS: 1US FAERS
376Acanthamoeba InfectionFAERS: 1US FAERS
377AcidosisFAERS: 1US FAERS
378Administration site extravasationFAERS: 1US FAERS
379AgnosiaFAERS: 1US FAERS
380AlbuminuriaFAERS: 1US FAERS
381Anal UlcerFAERS: 1US FAERS
382AngerFAERS: 1US FAERS
383Angina PectorisFAERS: 1US FAERS
384AnhedoniaFAERS: 1OFFSIDES
US FAERS
385Anti-thyroid antibody positiveFAERS: 1US FAERS
386ApathyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
387AphoniaFAERS: 1US FAERS
388Application site drynessFAERS: 1US FAERS
389Application site erosionFAERS: 1US FAERS
390Application site exfoliationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
391Application site inflammationFAERS: 1US FAERS
392Application site lacerationFAERS: 1US FAERS
393Application site scarFAERS: 1US FAERS
394Application site swellingFAERS: 1US FAERS
395AspergillosisFAERS: 1US FAERS
396AsthenopiaFAERS: 1US FAERS
397Atrial FibrillationFAERS: 1US FAERS
398Auricular swellingFAERS: 1US FAERS
399Axonal neuropathyFAERS: 1US FAERS
400Biopsy skin abnormalFAERS: 1US FAERS
401Bladder painFAERS: 1US FAERS
402Blood alkaline phosphatase increasedFAERS: 1OFFSIDES
SIDER
US FAERS
403Blood creatinine abnormalFAERS: 1US FAERS
404Blood fibrinogen decreasedFAERS: 1US FAERS
405Bone painFAERS: 1OFFSIDES
US FAERS
406BrucellosisFAERS: 1US FAERS
407Bullous impetigoFAERS: 1US FAERS
408CD4 Lymphocytes DecreasedFAERS: 1US FAERS
409Candida test positiveFAERS: 1US FAERS
410CandidiasisFAERS: 1US FAERS
411Catheter site erythemaFAERS: 1US FAERS
412Catheter site necrosisFAERS: 1US FAERS
413Central nervous system lesionFAERS: 1US FAERS
414ChillsFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
415Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
416ClonusFAERS: 1US FAERS
417Coma scale abnormalFAERS: 1US FAERS
418Complications of maternal exposure to therapeutic drugsFAERS: 1US FAERS
419Congenital cystic kidney diseaseFAERS: 1US FAERS
420ConjunctivitisFAERS: 1
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
421Consciousness fluctuatingFAERS: 1US FAERS
422Corneal PerforationFAERS: 1US FAERS
423Cotard's syndromeFAERS: 1US FAERS
424Creatinine renal clearance decreasedFAERS: 1US FAERS
425Crystal urine presentFAERS: 1US FAERS
426Culture urine positiveFAERS: 1US FAERS
427CyanopsiaFAERS: 1US FAERS
428Cytomegalovirus chorioretinitisFAERS: 1US FAERS
429Cytomegalovirus gastroenteritisFAERS: 1US FAERS
430Cytomegalovirus hepatitisFAERS: 1US FAERS
431Decreased immune responsivenessFAERS: 1US FAERS
432Device FailureFAERS: 1US FAERS
433Device ineffectiveFAERS: 1US FAERS
434Device related infectionFAERS: 1US FAERS
435Diabetic KetoacidosisFAERS: 1US FAERS
436Dialysis device insertionFAERS: 1US FAERS
437Dreamy stateFAERS: 1US FAERS
438Drug administered at inappropriate siteFAERS: 1US FAERS
439Drug dose titration not performedFAERS: 1US FAERS
440Drug effective for unapproved indicationFAERS: 1US FAERS
441Drug exposure via breast milkFAERS: 1US FAERS
442Drug level above therapeuticFAERS: 1US FAERS
443Drug level below therapeuticFAERS: 1US FAERS
444Drug monitoring procedure not performedFAERS: 1US FAERS
445DysenteryFAERS: 1US FAERS
446DyspepsiaFAERS: 1OFFSIDES
SIDER
US FAERS
447EcchymosisFAERS: 1US FAERS
448EnterocolitisFAERS: 1US FAERS
449EscharFAERS: 1US FAERS
450Eye inflammationFAERS: 1US FAERS
451Eyeball avulsionFAERS: 1US FAERS
452Eyelid margin crustingFAERS: 1US FAERS
453Eyelid painFAERS: 1US FAERS
454FasciitisFAERS: 1US FAERS
455Febrile NeutropeniaFAERS: 1OFFSIDES
US FAERS
456Feeling ColdFAERS: 1US FAERS
457Feeling jitteryFAERS: 1US FAERS
458Feeling of body temperature changeFAERS: 1US FAERS
459FibrosisFAERS: 1US FAERS
460Fluid overloadFAERS: 1OFFSIDES
US FAERS
461Gastric mucosa erythemaFAERS: 1US FAERS
462GastritisFAERS: 1US FAERS
463Gastrointestinal PainFAERS: 1SIDER
US FAERS
464Gastrointestinal mucosal disorderFAERS: 1US FAERS
465Gaze palsyFAERS: 1US FAERS
466Gene MutationFAERS: 1US FAERS
467General symptomFAERS: 1US FAERS
468Genital discomfortFAERS: 1US FAERS
469Genital rashFAERS: 1US FAERS
470GlossitisFAERS: 1US FAERS
471Gluten sensitivityFAERS: 1US FAERS
472GlycosuriaFAERS: 18442906CTD
US FAERS
473Graft versus host disease in lungFAERS: 1US FAERS
474HELLP SyndromeFAERS: 1US FAERS
475HemiplegiaFAERS: 1US FAERS
476HepatosplenomegalyFAERS: 1OFFSIDES
US FAERS
477Herpes Zoster OticusFAERS: 119278487CTD
US FAERS
478Herpes simplex DNA test positiveFAERS: 1US FAERS
479Herpes simplex serology positiveFAERS: 1US FAERS
480Herpes zoster meningomyelitisFAERS: 1US FAERS
481Histiocytosis haematophagicFAERS: 1OFFSIDES
US FAERS
482HydrocephalusFAERS: 1US FAERS
483HypercreatininaemiaFAERS: 1US FAERS
484HyperreflexiaFAERS: 1OFFSIDES
US FAERS
485Hypertensive crisisFAERS: 1US FAERS
486HyperventilationFAERS: 1US FAERS
487HypomaniaFAERS: 1US FAERS
488Hyporesponsive to stimuliFAERS: 1US FAERS
489ImmobileFAERS: 1US FAERS
490Immune reconstitution syndromeFAERS: 1US FAERS
491ImpatienceFAERS: 1US FAERS
492Inappropriate schedule of product administrationFAERS: 1US FAERS
493Incorrect product administration durationFAERS: 1US FAERS
494Increased tendency to bruiseFAERS: 1US FAERS
495Infection reactivationFAERS: 1US FAERS
496InflammationFAERS: 1SIDER
US FAERS
497InfluenzaFAERS: 1US FAERS
498Infusion site erosionFAERS: 1US FAERS
499Infusion site reactionFAERS: 1US FAERS
500Injection site inflammationFAERS: 1US FAERS
501Injection site painFAERS: 1US FAERS
502Injection site phlebitisFAERS: 1SIDER
US FAERS
503Instillation site vesiclesFAERS: 1US FAERS
504Intellectual DisabilityFAERS: 1US FAERS
505Intentional drug misuseFAERS: 1US FAERS
506Intentional product use issueFAERS: 1US FAERS
507Intercepted drug dispensing errorFAERS: 1US FAERS
508Intercepted medication errorFAERS: 1US FAERS
509Irregular breathingFAERS: 1US FAERS
510Irritable Bowel SyndromeFAERS: 1US FAERS
511JC virus infectionFAERS: 1US FAERS
512Joint stiffnessFAERS: 1US FAERS
513Joint swellingFAERS: 1US FAERS
514Leukocytoclastic vasculitisFAERS: 1SIDER
US FAERS
515LeukostasisFAERS: 1US FAERS
516Locked-In SyndromeFAERS: 1US FAERS
517Loss of personal independence in daily activitiesFAERS: 1US FAERS
518Lower respiratory tract infectionFAERS: 1US FAERS
519Lumbar puncture abnormalFAERS: 1US FAERS
520Lung consolidationFAERS: 1OFFSIDES
US FAERS
521LymphadenopathyFAERS: 1SIDER
US FAERS
522Lymphocyte count decreasedFAERS: 1US FAERS
523Lymphocyte percentage increasedFAERS: 1US FAERS
524Lymphocytic infiltrationFAERS: 1US FAERS
525LymphopeniaFAERS: 1US FAERS
526MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
527MeaslesFAERS: 1US FAERS
528Medication crystals in urine presentFAERS: 1US FAERS
529Medication residue presentFAERS: 1US FAERS
530MeningitisFAERS: 1US FAERS
531Mental impairmentFAERS: 1
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
532MetamorphopsiaFAERS: 1US FAERS
533MoaningFAERS: 1US FAERS
534Mood swingsFAERS: 1US FAERS
535Multi-organ disorderFAERS: 1US FAERS
536Multiple allergiesFAERS: 1US FAERS
537Muscle SpasticityFAERS: 1US FAERS
538Musculoskeletal chest painFAERS: 1OFFSIDES
US FAERS
539Musculoskeletal discomfortFAERS: 1SIDER
US FAERS
540Myocardial necrosis marker increasedFAERS: 1US FAERS
541MyopathyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
542MyopiaFAERS: 1US FAERS
543MyositisFAERS: 1US FAERS
544Neonatal hypotensionFAERS: 1US FAERS
545Neonatal infectionFAERS: 1US FAERS
546Neonatal mucocutaneous herpes simplexFAERS: 1US FAERS
547Nephritic syndromeFAERS: 1US FAERS
548NephrolithiasisFAERS: 1OFFSIDES
US FAERS
549NephrosclerosisFAERS: 1US FAERS
550Neutrophil percentage decreasedFAERS: 1US FAERS
551Oculomucocutaneous syndromeFAERS: 1US FAERS
552Oral candidiasisFAERS: 1US FAERS
553Oropharyngeal discomfortFAERS: 1SIDER
US FAERS
554Orthostatic intoleranceFAERS: 1US FAERS
555Osteonecrosis of JawFAERS: 1US FAERS
556Oxygen saturation abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
557PO2 decreasedFAERS: 1US FAERS
558Pain of skinFAERS: 1OFFSIDES
US FAERS
559PallorFAERS: 1OFFSIDES
US FAERS
560Penile erythemaFAERS: 1US FAERS
561Pericardial effusionFAERS: 1OFFSIDES
US FAERS
562PeriostosisFAERS: 1US FAERS
563Peritoneal DialysisFAERS: 1US FAERS
564PetechiaeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
565PleocytosisFAERS: 1US FAERS
566Pneumonia herpes viralFAERS: 1US FAERS
567PolyhydramniosFAERS: 1US FAERS
568PolymyositisFAERS: 1US FAERS
569PolyuriaFAERS: 114675048CTD
US FAERS
570PoriomaniaFAERS: 1US FAERS
571Post procedural complicationFAERS: 1OFFSIDES
US FAERS
572Prescribed overdoseFAERS: 1US FAERS
573Procedural complicationFAERS: 1US FAERS
574Product adhesion issueFAERS: 1US FAERS
575Product comminglingFAERS: 1US FAERS
576Product contaminationFAERS: 1US FAERS
577Product contamination physicalFAERS: 1US FAERS
578Product difficult to swallowFAERS: 1US FAERS
579Product dispensing errorFAERS: 1US FAERS
580Product formulation issueFAERS: 1US FAERS
581Product packaging confusionFAERS: 1US FAERS
582Product size issueFAERS: 1US FAERS
583Product storage errorFAERS: 1US FAERS
584Product substitutionFAERS: 1US FAERS
585Product used for unknown indicationFAERS: 1US FAERS
586Prostatic painFAERS: 1US FAERS
587Protein urine presentFAERS: 1US FAERS
588Psychotic symptomFAERS: 1US FAERS
589Pulmonary EmbolismFAERS: 1US FAERS
590Pulmonary FibrosisFAERS: 1US FAERS
591PurpuraFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
592PurulenceFAERS: 1US FAERS
593RadiculopathyFAERS: 1US FAERS
594Reaction to excipientFAERS: 1US FAERS
595Renal ColicFAERS: 1US FAERS
596Respiratory DepressionFAERS: 1US FAERS
597Restless Legs SyndromeFAERS: 1US FAERS
598Retinal infiltratesFAERS: 1US FAERS
599Retinal scarFAERS: 1US FAERS
600Retrograde amnesiaFAERS: 1US FAERS
601Rhegmatogenous retinal detachmentFAERS: 1US FAERS
602SchizophreniaFAERS: 1US FAERS
603SclerodermaFAERS: 1OFFSIDES
US FAERS
604Sensation of blood flowFAERS: 1US FAERS
605Sensory level abnormalFAERS: 1US FAERS
606Skeleton dysplasiaFAERS: 1US FAERS
607Skin lacerationFAERS: 1US FAERS
608Specific gravity urine decreasedFAERS: 1US FAERS
609Spinal column stenosisFAERS: 1US FAERS
610SplenomegalyFAERS: 1US FAERS
611Squamous cell carcinomaFAERS: 1US FAERS
612Sterile pyuriaFAERS: 1US FAERS
613StillbirthFAERS: 1US FAERS
614StressFAERS: 1US FAERS
615StuporFAERS: 12396095
7973922
12799156
CTD
SIDER
US FAERS
616SunburnFAERS: 1US FAERS
617Synovial fluid white blood cells positiveFAERS: 1US FAERS
618SyphilisFAERS: 1US FAERS
619Systemic mycosisFAERS: 1US FAERS
620TensionFAERS: 1US FAERS
621Therapeutic product effect incompleteFAERS: 1US FAERS
622Therapy non-responderFAERS: 1US FAERS
623Thermal burnFAERS: 1US FAERS
624Thrombocytopenic purpuraFAERS: 1SIDER
US FAERS
625ThrombocytosisFAERS: 1
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
626Tongue eruptionFAERS: 1US FAERS
627Tooth LossFAERS: 1US FAERS
628Traumatic lumbar punctureFAERS: 1US FAERS
629Urine leukocyte esterase positiveFAERS: 1US FAERS
630Urine output increasedFAERS: 1US FAERS
631Vaginal DischargeFAERS: 1US FAERS
632Varicella Zoster Virus InfectionFAERS: 1US FAERS
633Vascular access site occlusionFAERS: 1US FAERS
634Vascular encephalopathyFAERS: 1US FAERS
635Venous thrombosis limbFAERS: 1OFFSIDES
US FAERS
636Ventricular FibrillationFAERS: 1US FAERS
637Vulvar erosionFAERS: 1US FAERS
638Vulvovaginal burning sensationFAERS: 1US FAERS
639Wheelchair userFAERS: 1US FAERS
640XanthopsiaFAERS: 1US FAERS
641skin abrasionFAERS: 1US FAERS
642AIDS-Related Opportunistic Infections9707315CTD
643Abnormal visionOFFSIDES
644AbscessOFFSIDES
645Accelerated hair lossSIDER
646AcheSIDER
647Acid refluxOFFSIDES
648Acquired Immunodeficiency Syndrome2964805CTD
649Actinic keratosisOFFSIDES
650ActinomycosisOFFSIDES
651Activities of daily living impairedOFFSIDES
652Acute graft versus host disease in intestineOFFSIDES
653Acute graft versus host disease in liverOFFSIDES
654Acute psychosisOFFSIDES
655Acute respiratory failureOFFSIDES
656Acute sinusitisOFFSIDES
657Acute vestibular syndromeOFFSIDES
658AdenocarcinomaOFFSIDES
659AdenomaOFFSIDES
660Allergic pharyngitisOFFSIDES
661AlveolitisOFFSIDES
662Anemia, Megaloblastic6130274CTD
663Antithrombin III decreasedOFFSIDES
664Aortic bruitOFFSIDES
665Aphthous StomatitisOFFSIDES
SIDER
666Application site warmthCanada Vigilance: 1Canada Vigilance
667ArteriosclerosisOFFSIDES
668Arteriovenous fistula thrombosisOFFSIDES
669ArthropathyOFFSIDES
670Aseptic MeningitisOFFSIDES
671AtelectasisOFFSIDES
672Atrial FlutterOFFSIDES
673Atrial bigeminyOFFSIDES
674Atrial tachycardiaCanada Vigilance: 1Canada Vigilance
OFFSIDES
675Auditory and visual hallucinationsSIDER
676AuraOFFSIDES
677Autoimmune hepatitisOFFSIDES
678Bacterial Infections12669766CTD
679Band neutrophil percentage decreasedOFFSIDES
680Basal cell carcinomaOFFSIDES
681Bile duct necrosisOFFSIDES
682Biliary DyskinesiaOFFSIDES
683Biliary cancer metastaticOFFSIDES
684Biopsy bone marrow abnormalOFFSIDES
685Biopsy endometrium abnormalOFFSIDES
686Bipolar Disorder7969690CTD
687Bladder DiverticulumOFFSIDES
688BlepharitisSIDER
689Blood 1,25-dihydroxycholecalciferol decreasedOFFSIDES
690Blood GlucoseOFFSIDES
691Blood albumin decreasedOFFSIDES
692Blood and lymphatic system disordersSIDER
693Blood chloride decreasedOFFSIDES
694Blood cholesterolOFFSIDES
695Blood magnesium increasedOFFSIDES
696Blood sodium increasedOFFSIDES
697Blood sodiumOFFSIDES
698Blood uric acidOFFSIDES
699Bone lesionOFFSIDES
700Bone marrow depressionOFFSIDES
701Breast CystOFFSIDES
702BronchiolitisOFFSIDES
703BronchitisOFFSIDES
704Bronchoalveolar LavageOFFSIDES
705Bronchoalveolar lavage abnormalOFFSIDES
706CalciphylaxisOFFSIDES
707Cancer PainOFFSIDES
708Cardiac TamponadeOFFSIDES
SIDER
709Cardiovascular insufficiencyOFFSIDES
710CarotidyniaOFFSIDES
711Cataract operationOFFSIDES
712Central Nervous System InfectionOFFSIDES
713Cerebral cystOFFSIDES
714Chemical and Drug Induced Liver Injury11214960
24085192
CTD
715Choking sensationOFFSIDES
716CholangiolitisOFFSIDES
717Chorea2843139CTD
718Choroidal DetachmentOFFSIDES
719Chronic Obstructive Airway DiseaseOFFSIDES
720Chronic sinusitisOFFSIDES
721Clostridium colitisOFFSIDES
722Clostridium difficile colitisOFFSIDES
723Compression fractureOFFSIDES
724Confusion

View details

CTD
725Creatinine increasedSIDER
726Cytomegalovirus Infections2837588
3030175
7947045
CTD
727Cytomegalovirus antibody positiveOFFSIDES
728Cytomegalovirus test positiveOFFSIDES
729DebridementOFFSIDES
730DemyelinationOFFSIDES
731Dental FistulaOFFSIDES
732Dental cariesOFFSIDES
733Depressive disorder3371192
3711686
CTD
734DiarrheaOFFSIDES
735Diffuse Large B-Cell LymphomaOFFSIDES
736Dilatation intrahepatic duct acquiredOFFSIDES
737Distress gastrointestinalSIDER
738DiverticulitisOFFSIDES
739DiverticulosisOFFSIDES
740EndocarditisOFFSIDES
741Endodontic procedureOFFSIDES
742Enterococcal infectionOFFSIDES
743Enterocutaneous FistulaOFFSIDES
744EpiscleritisOFFSIDES
745Epstein-Barr virus antibody positiveOFFSIDES
746Epstein-Barr virus associated lymphoproliferative disorderOFFSIDES
747Escherichia infectionOFFSIDES
748Escherichia urinary tract infectionOFFSIDES
749Eye laser surgeryOFFSIDES
750Facial Nerve Diseases19278487CTD
751Febrile infectionOFFSIDES
752FolliculitisOFFSIDES
753Foreign body traumaOFFSIDES
754Fungus serology test positiveOFFSIDES
755Genital erosionOFFSIDES
756Gingival HypertrophyOFFSIDES
757GlobulinuriaOFFSIDES
758GoiterOFFSIDES
759GranulomaOFFSIDES
760Growth failureCanada Vigilance: 1Canada Vigilance
761HaematotoxicityOFFSIDES
762Hallucinations

View details

CTD
763Heparin-induced thrombocytopeniaOFFSIDES
764Hepatitis COFFSIDES
765Herpes NOSSIDER
766Herpes Zoster Ophthalmicus14606623CTD
767Herpesviridae Infections2729341
3711686
CTD
768HiccoughOFFSIDES
769HydronephrosisOFFSIDES
770Hypertrophy of tongue papillaeOFFSIDES
771Hypophosphatemia8456495
14675048
CTD
772HypoxiaOFFSIDES
773ImmunosuppressionOFFSIDES
774Instillation site painSIDER
775Intention tremorOFFSIDES
776Intervertebral disc disorderOFFSIDES
777Keratitis siccaOFFSIDES
778KeratomileusisOFFSIDES
779Kidney Diseases11532999CTD
780Kidney Failure, Chronic14606623
16138435
CTD
781Kidney FailureOFFSIDES
782Klebsiella sepsisOFFSIDES
783Large intestine perforationOFFSIDES
784LeukoencephalopathyOFFSIDES
785Leukopenia neonatalOFFSIDES
786Life expectancy shortenedOFFSIDES
787LightheadednessSIDER
788Limb operationOFFSIDES
789LipaseOFFSIDES
790Liver transplant rejectionOFFSIDES
791Loose toothOFFSIDES
792Lower respiratory tract infection fungalOFFSIDES
793Lung hyperinflationOFFSIDES
794Lung infection pseudomonalOFFSIDES
795LymphomaOFFSIDES
796Mastication disorderOFFSIDES
797Memory Disorders7571352
17651180
CTD
798Meningoencephalitis1476483
10615548
16854507
CTD
799MetrorrhagiaCanada Vigilance: 1Canada Vigilance
800Mucosal erosionOFFSIDES
801Multiple MyelomaOFFSIDES
802Muscle strainOFFSIDES
803Mycobacterium avium complex immune restoration diseaseOFFSIDES
804MyelodysplasiaOFFSIDES
805Nephritis, Interstitial2080005
3376977
CTD
806Neural Tube Defects1810578CTD
807Neurobehavioral Manifestations8213806CTD
808Neurologic Manifestations

View details

CTD
809Neurologic reactionSIDER
810Neurotoxicity Syndromes

View details

CTD
811NocturiaOFFSIDES
812Oral infectionOFFSIDES
813Oropharyngeal spasmOFFSIDES
814OsteolysisOFFSIDES
815OsteomyelitisOFFSIDES
816OsteopeniaOFFSIDES
817Pars PlanitisSIDER
818Pelvic abscessOFFSIDES
819PeriodontitisOFFSIDES
820Physical disabilityOFFSIDES
821PlasmacytomaOFFSIDES
822Platelet count abnormalOFFSIDES
823Pneumococcal sepsisOFFSIDES
824Pneumocystis jiroveci pneumoniaOFFSIDES
825Portal Vein ThrombosisOFFSIDES
826Portal vein stenosisOFFSIDES
827Posterior Leukoencephalopathy Syndrome16107379CTD
828Product complaintCanada Vigilance: 1Canada Vigilance
829Productive CoughOFFSIDES
830Pseudomonal sepsisOFFSIDES
831Psychomotor Agitation8228796CTD
832Pulmonary InfarctionOFFSIDES
833Pulmonary congestionOFFSIDES
834Purpura FulminansSIDER
835Quality of life decreasedOFFSIDES
836Radicular painOFFSIDES
837Renal Insufficiency

View details

CTD
838Respiratory tract infection fungalOFFSIDES
839Retinal Necrosis Syndrome, Acute17406046
19278487
CTD
840Retinal infarctionOFFSIDES
841Seizures8038467
14658398
19589454
CTD
842Shoulder PainOFFSIDES
843Sinus polypOFFSIDES
844Skin Diseases, Vesiculobullous3510331CTD
845Sleep Initiation and Maintenance Disorders8825003CTD
846Soft Tissue InfectionOFFSIDES
847Soft tissue inflammationOFFSIDES
848SplenectomyOFFSIDES
849Splenic abscessOFFSIDES
850Squamous cell carcinoma of skinOFFSIDES
851Stem cell transplantOFFSIDES
852Superficial punctate keratopathySIDER
853Synovial CystOFFSIDES
854Tension HeadacheOFFSIDES
855Tooth ExtractionOFFSIDES
856ToxoplasmosisOFFSIDES
857Tracheobronchitis viralOFFSIDES
858TracheobronchitisOFFSIDES
859Transfusion ReactionOFFSIDES
860Umbilical herniaOFFSIDES
861Urolithiasis11895069CTD
862UveitisSIDER
863Vascular calcificationOFFSIDES
864Viral DNA test positiveOFFSIDES
865Viral pharyngitisOFFSIDES
866Weight GainOFFSIDES
867West Nile viral infectionOFFSIDES
868Wound ComplicationOFFSIDES
869Wound dehiscenceOFFSIDES
870prostatitisOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.